SCHEDULE 13G: Glazer Capital and Paul J. Glazer Disclose 6.71% Stake in Aimei Health Technology Co Ltd

Investment firm Glazer Capital, LLC and its Managing Member Paul J. Glazer have disclosed a 6.71% beneficial ownership stake in Aimei Health Technology Co Ltd, holding 605,795 ordinary shares.

Summary

• Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G with the SEC, reporting beneficial ownership of Aimei Health Technology Co Ltd's ordinary shares.
• The reporting persons collectively own 605,795 ordinary shares of Aimei Health Technology Co Ltd.
• This ownership represents 6.71% of the total outstanding ordinary shares of the company.
• Glazer Capital, LLC acts as the investment manager for certain funds and managed accounts (referred to as the Glazer Funds) that hold these shares.
• Paul J. Glazer is the Managing Member of Glazer Capital, LLC and is also a reporting person.
• The shares are held with shared voting power and shared dispositive power by both Glazer Capital, LLC and Paul J. Glazer.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates a significant beneficial ownership stake by an institutional investor, which can be viewed as a vote of confidence, though the document itself is purely a disclosure of ownership and does not contain performance or operational details.

Positives

• Disclosure of a significant ownership stake (6.71%) by an institutional investor (Glazer Capital, LLC) and its principal (Paul J. Glazer) in Aimei Health Technology Co Ltd.
• The filing indicates that the shares were acquired in the ordinary course of business, suggesting an investment intent rather than an activist one, which can be viewed positively by the market.

Negatives

• No specific negative information about Aimei Health Technology Co Ltd's operations or financial performance is contained within this ownership disclosure filing.

Risks

• No specific risks related to Aimei Health Technology Co Ltd's operations or financial health are disclosed in this Schedule 13G filing, as it is primarily an ownership disclosure.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding significant ownership stakes, potentially influencing market perception and trading activity as a new institutional investor has disclosed a substantial position.

Key Dates

Keywords

Aimei Health Technology Co Ltd, Glazer Capital, Paul J. Glazer, Schedule 13G, beneficial ownership, ordinary shares, SEC filing, institutional investment, G01341109